Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy
暂无分享,去创建一个
H. Moser | A. Moser | J. Powers | H W Moser | J M Powers | A B Moser | M Ito | D P DeCiero | Masumi Ito | David P. Deciero
[1] B. Lemieux,et al. Ultrastructural Observations on Spinal Ganglion Biopsy in Friedreich’s Ataxia: A Preliminary Report , 1982, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[2] C. Raine,et al. Adrenomyeloneuropathy , 1977, Neurology.
[3] J. Ulrich,et al. Adrenomyeloneuropathy. A protracted, pseudosystematic variant of adrenoleukodystrophy. , 1980, Acta neuropathologica.
[4] H. Moser,et al. THE MYELOPATHY OF ADRENOMYELONEUROPATHY (AMN) , 1993 .
[5] H. Quincke,et al. Die Krankheiten der Leber . Die Erkrankunkugen des Pankreas . Die Erkrankungen der Nebennieren , 1899 .
[6] H. Moser,et al. Adrenoleukodystrophy: Molecular Genetics, Pathology, and Lorenzo's oil , 1995, Brain pathology.
[7] J. Mandel,et al. Adrénoleucodystrophie liée à l'X , 2007 .
[8] J. Dave,et al. Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy. , 1983, The Journal of clinical investigation.
[9] H. Moser,et al. Cognitive and brain magnetic resonance imaging findings in adrenomyeloneuropathy , 1996, Annals of neurology.
[10] J. Martín,et al. Adrenomyeloneuropathy. A report on two families. , 1982, Journal of neurology.
[11] B. Brownell,et al. Pathology of peroneal muscular atrophy (Charcot-Marie-Tooth disease) , 1972, Journal of neurology, neurosurgery, and psychiatry.
[12] G. Sobue,et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. , 1989, Brain : a journal of neurology.
[13] C. Raine,et al. A correlative study of the adrenal cortex in adreno-leukodystrophy--evidence for a fatal intoxication with very long chain saturated fatty acids. , 1980, Investigative & cell pathology.
[14] J. Greenfield,et al. The Spino‐Cerebellar Degenerations , 1955, Neurology.
[15] R. Marchase,et al. Gangliosides as modulators of cell function. , 1992, The American journal of physiology.
[16] J. Powers,et al. The testis in adreno-leukodystrophy. , 1981, The American journal of pathology.
[17] G. Said,et al. Hypotrophic and dying‐back nerve fibers in Friedreich's ataxia , 1986, Neurology.
[18] R. Hewer,et al. The peripheral sensory pathway in friedreich's ataxia. An examination by light and electron microscopy of the posterior nerve roots, posterior root ganglia, and peripheral sensory nerves in cases of friedreich's ataxia. , 1968, Brain : a journal of neurology.
[19] K. Suzuki,et al. Brain gangliosides in adrenoleukodystrophy 1 , 1976 .
[20] D. Pain,et al. The yeast connection to Friedreich ataxia. , 1999, American journal of human genetics.
[21] T. Crawford,et al. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Waxman. Determinants of conduction velocity in myelinated nerve fibers , 1980, Muscle & nerve.
[23] D. Shapcott,et al. Erythrocyte Membrane Lipids in Fríedreich's Ataxia , 1979, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[24] Scott T. Brady,et al. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells , 1992, Cell.
[25] W. Engel,et al. Adrenomyeloneuropathy , 1977, Neurology.
[26] J. Powers,et al. Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex). , 1985, Clinical neuropathology.
[27] P. Aubourg,et al. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder , 1999, Trends in Neurosciences.
[28] H. Moser,et al. Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis. , 1982, Human pathology.
[29] H. Moser,et al. The Inflammatory Myelinopathy of Adreno‐Leukodystrophy: Cells, Effector Molecules, and Pathogenetic Implications , 1992, Journal of neuropathology and experimental neurology.
[30] P. Nixon,et al. Familial Addison's disease with spastic paraplegia. , 1955, The Journal of clinical endocrinology and metabolism.
[31] P. Barth,et al. Peripheral nerve abnormalities in adrenomyeloneuropathy , 1996, Neurology.
[32] H. Moser,et al. A mouse model for X-linked adrenoleukodystrophy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Knazek,et al. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. , 1988, The Journal of clinical investigation.
[34] T. Satoh,et al. Adrenoleukodystrophy. Report of an autopsy case with adrenoleukomyeloneuropathy. , 1986, Acta pathologica japonica.
[35] D. Darriet,et al. Adrenomyeloneuropathy: demonstration of inclusions at the level of the peripheral nerve. , 1981, European neurology.
[36] H. Moser,et al. THE DORSAL ROOT GANGLIA IN ADRENOMYELO-NEUROPATHY (AMN) , 1999 .
[37] Powers Jm. Adreno-leukodystrophy (adreno-testiculo-leukomyelo-neuropathic-complex). , 1985 .
[38] S. Murayama,et al. Pathological study of corticospinal‐tract degeneration in Friedreich's ataxia , 1992, Neuropathology and applied neurobiology.
[39] O. Combarros,et al. Hereditary motor and sensory neuropathy type II. Clinicopathological study of a family. , 1986, Brain : a journal of neurology.
[40] J. Martín,et al. Adrenomyeloneuropathy and adrenoleukodystrophy in two brothers. , 1980, European neurology.
[41] J. Powers. The pathology of peroxisomal disorders with pathogenetic considerations. , 1995, Journal of neuropathology and experimental neurology.
[42] R. Penman. Addison's Disease in Association with Spastic Paraplegia , 1960, British medical journal.
[43] H. Moser,et al. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter. , 1997, Archives of neurology.
[44] K. Suzuki,et al. FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHY , 1976, Journal of neurochemistry.
[45] J. Powers,et al. Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. , 1974, The American journal of pathology.
[46] 三宅 みどり. Adreno-leukodystrophy--Sex-linked Schilder disease (先天性機能異常の臨床 ) , 1979 .
[47] R. Wanders,et al. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “Lorenzo’s oil” , 1999, Journal of neurology, neurosurgery, and psychiatry.
[48] A. J. Kumar,et al. MR findings in adult-onset adrenoleukodystrophy. , 1995, AJNR. American journal of neuroradiology.
[49] K Suzuki,et al. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. , 1975, Archives of neurology.
[50] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[51] J. Cavanagh. The significance of the "dying back" process in experimental and human neurological disease. , 1964, International review of experimental pathology.
[52] A. Barbeau,et al. Fatty Acid Profile of Major Lipid Classes in Plasma Lipoproteins of Patients with Friedreich's Ataxia — Demonstration of a Low Linoleic Acid Content most evident in the Cholesterol-Ester Fraction , 1979, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[53] Cavanagh Jb. The significance of the "dying back" process in experimental and human neurological disease. , 1964 .
[54] S. Tsuji,et al. Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy. , 1999, Archives of neurology.
[55] P. Spencer,et al. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? , 1979, Annals of neurology.
[56] H. Moser,et al. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. , 1997, Brain : a journal of neurology.
[57] P. Barth,et al. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy , 1997, Journal of neurology, neurosurgery, and psychiatry.
[58] H. Moser,et al. Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. , 1995, The Journal of clinical investigation.
[59] Jonathan D. Glass,et al. Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination , 1992, Journal of Neuroimmunology.
[60] H. Moser,et al. Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis , 1998 .
[61] A. J. Kumar,et al. The adrenoleukodystrophies. , 1987, Critical reviews in neurobiology.
[62] U. de Girolami,et al. Hereditary Ataxia with Sensory Neuronopathy , 1997, Neurology.
[63] T. Deerinck,et al. The distribution of ganglioside-like moieties in peripheral nerves. , 1999, Brain : a journal of neurology.
[64] C. Raine,et al. THE MYELONEUROPATHY VARIANT OF ADRENOLEUKODYSTROPHY: 26 , 1976 .